scholarly journals Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function

2009 ◽  
Vol 1 (2) ◽  
pp. 99-111 ◽  
Author(s):  
Vanessa A. Morais ◽  
Patrik Verstreken ◽  
Anne Roethig ◽  
Joél Smet ◽  
An Snellinx ◽  
...  
1994 ◽  
Vol 169 (1-2) ◽  
pp. 126-128 ◽  
Author(s):  
Bernd Janetzky ◽  
Sabine Hauck ◽  
Moussa B.H. Youdim ◽  
Peter Riederer ◽  
Kurt Jellinger ◽  
...  

2017 ◽  
Vol 42 (6) ◽  
pp. 1676-1682 ◽  
Author(s):  
Irene Lopez-Fabuel ◽  
Monica Resch-Beusher ◽  
Monica Carabias-Carrasco ◽  
Angeles Almeida ◽  
Juan P. Bolaños

2011 ◽  
Vol 192 (5) ◽  
pp. 873-882 ◽  
Author(s):  
Won-Seok Choi ◽  
Richard D. Palmiter ◽  
Zhengui Xia

Mitochondrial complex I dysfunction is regarded as underlying dopamine neuron death in Parkinson’s disease models. However, inactivation of the Ndufs4 gene, which compromises complex I activity, does not affect the survival of dopamine neurons in culture or in the substantia nigra pars compacta of 5-wk-old mice. Treatment with piericidin A, a complex I inhibitor, does not induce selective dopamine neuron death in either Ndufs4+/+ or Ndufs4−/− mesencephalic cultures. In contrast, rotenone, another complex I inhibitor, causes selective toxicity to dopamine neurons, and Ndufs4 inactivation potentiates this toxicity. We identify microtubule depolymerization and the accumulation of cytosolic dopamine and reactive oxygen species as alternative mechanisms underlying rotenone-induced dopamine neuron death. Enhanced rotenone toxicity to dopamine neurons from Ndufs4 knockout mice may involve enhanced dopamine synthesis caused by the accumulation of nicotinamide adenine dinucleotide reduced. Our results suggest that the combination of disrupting microtubule dynamics and inhibiting complex I, either by mutations or exposure to toxicants, may be a risk factor for Parkinson’s disease.


Sign in / Sign up

Export Citation Format

Share Document